Insights on Clinical Trials

  1. How CGT Leaders Are Reducing Failures, Scaling Processes, And Overcoming Regulatory Friction 6/30/2025

     Industry leaders share their philosophy on reducing product failure, embracing AI, and building dynamic teams to stay ahead of the curve to bring curative CGT therapies to patients.

  2. Driving Greater Efficiency Through Modular Trial Design 6/27/2025

    As clinical trials grow more complex and patient-centric, traditional site-based models are proving insufficient and prompting the rise of modular, technology-enabled delivery strategies.

  3. Expert Guidance For EU Gene Therapy And Companion Diagnostic Trial Regulations 6/27/2025

    This playbook provides a concise yet comprehensive roadmap for navigating Europe’s multifaceted regulatory environment when conducting gene therapy trials involving GMOs and CDx.

  4. Ethical, Considerations As Gene Editing Technologies Advance 6/26/2025

    Observe as experts highlight innovative tools and strategies advancing the safety of gene editing therapies while addressing off-target effects, regulatory demands, and manufacturing efficiency.

  5. How The Pharma Industry Is Closing Health Inequities 6/26/2025

    Witness as pharma leaders discuss advancing equity through inclusive trial design, access planning, and global partnerships to overcome persistent health disparities and expand access to lifesaving therapies worldwide.

  6. Expanding Clinical Trials Internationally In The ATMP Space 6/26/2025

    Discover how the global expansion of ATMP trials offers significant advantages but demands early, strategic planning to overcome complex international challenges.

  7. Rapid Results In A High-Stakes Dry Eye Disease Trial 6/26/2025

    This time-sensitive Phase III trial in dry eye disease required precision project management leveraging strong site relationships, ophthalmology-specific expertise, and data-driven site selection.

  8. Global Start-Up For Multinational Geographic Atrophy Trial 6/26/2025

    This partnership allowed a leading biopharmaceutical company to navigate the complexities of a Phase IIb study investigating a novel pegylated RNA adapter for geographic atrophy secondary to dry AMD.

  9. Top Technologies Transforming Decentralized Clinical Trials 6/26/2025

    In today’s clinical development environment, DCT technologies are not optional innovations; they are essential drivers of more resilient, efficient, and patient-focused trials.

  10. Data-Driven Decision-Making In Clinical Trials 6/25/2025

    By leveraging real-time data and predictive tools, sponsors and CRO's can address the increasing complexity of trials, accelerate therapeutic development, and proactively manage risks.